Ross joined Novo Ventures (US) Inc. in 2020 as an associate. Previous to that, Ross was a senior associate at the JDRF T1D Fund, a venture philanthropy investing in life science companies developing therapies and devices for Type 1 Diabetes. Before joining the T1D Fund, he worked as a management consultant with The Boston Consulting Group focusing on pharmaceutical clients. Prior to this, Ross was a Fulbright Scholar in Peru working on public health and epidemiology. Ross holds an MD from Stanford University and a BS in Human Biology from the University of California, San Diego. Ross is based in our San Francisco office.